Adhérent PreciDIAB : Novo Nordisk

Novo Nordisk is an international pharmaceutical company headquartered in Copenhagen, Denmark. We specialize in the treatment of diabetes and other serious chronic diseases such as obesity, rare bleeding diseases and growth disorders.

We employ more than 45,000 people in 80 subsidiaries around the world. Our healthcare solutions are available in 169 countries.

Joining the PreciDIAB initiative club means participating in excellent research on diabetes, but also collaborating with public and private institutional partners in prevention and health promotion programs.